BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36880525)

  • 1. Bioinformatic analysis of the clinicopathological and prognostic significance of oocyte-arresting BTG4 mRNA expression in gynecological cancers.
    Zheng HC; Xue H; Zhang CY; Zhang R
    J Obstet Gynaecol; 2023 Dec; 43(1):2182672. PubMed ID: 36880525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bioinformatics analysis of the clinicopathological and prognostic significance of
    Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L
    J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bioinformatics analysis of the clinicopathological and prognostic significances of REG4 mRNA in gynecological cancers.
    Zhang CY; Zhang L; Wang ZM; Ren DH; Zheng HC
    J Obstet Gynaecol; 2023 Dec; 43(1):2213764. PubMed ID: 37218920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics analysis of the clinicopathological and prognostic significance of BAG3 mRNA in gynecological cancers.
    Wang ZM; Zhang L; Ren DH; Zhang CY; Zheng HC
    J Obstet Gynaecol; 2023 Dec; 43(2):2228899. PubMed ID: 37377218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
    He Y; Wang Y; Ji C; Liu Y; Wu YM
    Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
    [No Abstract]   [Full Text] [Related]  

  • 6. The oncogenic roles of GPR176 in ovarian cancer: a molecular target for aggressiveness and gene therapy.
    Yang N; Yun WJ; Cui ZG; Zheng HC
    J Obstet Gynaecol; 2024 Dec; 44(1):2347430. PubMed ID: 38835234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of
    Zheng HC; Xue H; Zhang CY; Shi KH; Zhang R
    Front Genet; 2022; 13():1006636. PubMed ID: 36339000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis.
    Zhang C; Yang Q
    Front Oncol; 2020; 10():572203. PubMed ID: 33634012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinicopathological and prognostic significances of Dkk3 expression in cancers: A bioinformatics analysis.
    Chen GY; Zheng HC
    Cancer Biomark; 2018; 23(3):323-331. PubMed ID: 29843219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematologic markers of distant metastases and poor prognosis in gynecological cancers.
    Abu-Shawer O; Abu-Shawer M; Hirmas N; Alhouri A; Massad A; Alsibai B; Sultan H; Hammo H; Souleiman M; Shebli Y; Al-Hussaini M
    BMC Cancer; 2019 Feb; 19(1):141. PubMed ID: 30755184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic roles of GPR176 in breast cancer: a potential marker of aggressiveness and a potential target of gene therapy.
    Yun WJ; Xue H; Yang N; Xiao LJ; Sun HZ; Zheng HC
    Clin Transl Oncol; 2023 Oct; 25(10):3042-3056. PubMed ID: 37079213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinicopathological significances and related signal pathways of BTG3 mRNA expression in cancers: A bioinformatics analysis.
    Zheng HC; Xue H; Zhang CY; Shi KH; Zhang R
    Front Genet; 2022; 13():1006582. PubMed ID: 36186486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coiled-coil domain-containing protein-124 (Ccdc124) is a novel RNA binding factor up-regulated in endometrial, ovarian, and urinary bladder cancers.
    Arslan Ö; Soylu NK; Akillilar PT; Tazebay UH
    Cancer Biomark; 2021; 31(2):149-164. PubMed ID: 33896821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.
    Caruso JA; Karakas C; Zhang J; Yi M; Albarracin C; Sahin A; Bondy M; Liu J; Hunt KK; Keyomarsi K
    Breast Cancer Res; 2014; 16(6):3417. PubMed ID: 25551582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
    Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
    Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentivirus-mediated RNA interference targeting the long noncoding RNA HOTAIR inhibits proliferation and invasion of endometrial carcinoma cells in vitro and in vivo.
    Huang J; Ke P; Guo L; Wang W; Tan H; Liang Y; Yao S
    Int J Gynecol Cancer; 2014 May; 24(4):635-42. PubMed ID: 24758900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BTG4 is A Novel p53 Target Gene That Inhibits Cell Growth and Induces Apoptosis.
    Zhang N; Jiang T; Wang Y; Wang S; Hu L; Bu Y
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32093041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management.
    Psilopatis I; Pergaris A; Vrettou K; Tsourouflis G; Theocharis S
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.